# Relmada Therapeutics, Inc.: Form 8-K, filed Jan 5, 2021

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2021-01-05
- Accepted by EDGAR: Jan 5, 2021, 16:01 ET
- Period: 2020-12-31
- Accession: 0001213900-21-000428
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390021000428/ea132757-8k_relmadathera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390021000428/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390021000428/ea132757-8k_relmadathera.htm

Filed Jan 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-000428. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
